Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What CAGR Will the Diabetic Neuropathy Market Achieve During 2025–2034, and What Does It Indicate?

The market size for diabetic neuropathy has experienced robust growth in the past few years. The market’s value which is set to increase from $5.79 billion in 2024 to $6.27 billion in 2025, predicts a compound annual growth rate (CAGR) of 8.3%. The historical period’s growth is credited to factors such as a rise in diabetes cases worldwide, heightened awareness and diagnostic exercises, improvements in diabetes care, increase in healthcare spending, funding in research and development, and initiatives in patient education.

The market for diabetic neuropathy is anticipated to undergo fast expansion in the forthcoming years. A growth to $9.3 billion is projected by 2029, with a compound annual growth rate (CAGR) of 10.4%. This predicted growth during the outlook period can be credited to the development in neuroimaging, focus on patient-oriented care, proliferation of clinical trials, constant increase in diabetes incidents, precision medicine methods, growth of regenerative medicine, as well as patient advocacy and support schemes. Key trends within the forecast period encompass cooperative endeavors in medical investigation, digital health solutions, progress in diagnostic technologies, neuroprotective treatments, customized treatment plans, and the incorporation of artificial intelligence.

What Major Innovations Are Driving the Accelerated Growth of the diabetic neuropathy Market?

The upward trend in diabetes occurrences is anticipated to spur the expansion of the diabetic neuropathy market. Diabetes is a chronic condition that impedes the body’s ability to utilize and store glucose efficiently. It arises when the body either doesn’t generate adequate insulin or doesn’t employ the insulin it does produce effectively. Diabetic neuropathy is a form of nerve damage linked with diabetes, leading to diverse symptoms based on the type of nerve damage. For instance, as per the report in August 2022 by the IDF Diabetes Atlas, produced by the International Diabetes Federation, a worldwide diabetes association based in Belgium, there were 6.7 million fatalities in 2021 due to diabetes, which is equivalent to one death every five seconds. Presently, 537 million adults aged between 20 and 79 or 1 in 10 people, are living with diabetes. This figure is projected to rise to 643 million by 2030 and 783 million by 2045. Hence, the increased diabetes cases are propelling the diabetic neuropathy market’s growth.

Get Your Free Sample of the Global Diabetic Neuropathy Market Report Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=9057&type=smp

Which Companies Are Redefining the Future of the Diabetic Neuropathy Market?

Major companies operating in the diabetic neuropathy market include:

• Pfizer Inc._x000D_

• Eli Lilly and Company_x000D_

• Daiichi Sankyo Company Limited_x000D_

• Johnson & Johnson_x000D_

• Depomed Inc._x000D_

What Trends Are Poised to Drive the Future Success of the Diabetic Neuropathy Market?

Leading firms in the diabetic neuropathy market are driving innovation through sophisticated products like neuromodulation therapy devices, which serve to broaden treatment alternatives for patients enduring chronic pain due to diabetic neuropathy. These devices for diabetic neuropathy propose non-invasive solutions that regulate nerve activity to alleviate pain, boost nerve function, and aid healing in patients dealing with diabetic nerve injury. For example, in January 2024, the U.S.-based company, Neuralace Medical Inc., which offers non-pharmacological treatment for pain management, earned FDA approval for its Axon Therapy for Chronic Painful Diabetic Neuropathy. The Axon Therapy device is specifically designed to treat chronic painful diabetic neuropathy (CPDN), using innovative neuromodulation techniques to deliver pain relief related to diabetic neuropathy, representing a notable development in available pain management options for those with this condition. The FDA’s approval attests to the safety and effectiveness of the device, facilitating Neuralace to commence commercialization and widen access to efficacious treatment methods for those afflicted by CPDN.

Get Instant Access to the Global Diabetic Neuropathy Market Report with Swift Delivery!

https://www.thebusinessresearchcompany.com/report/diabetic-neuropathy-global-market-report

Which Key Segments Define the Structure of the Diabetic Neuropathy Market and Their Growth Potential?

The diabetic neuropathy market covered in this report is segmented –

1) By Disorder: Peripheral Neuropathy, Autonomic Neuropathy, Proximal Neuropathy, Focal Neuropathy

2) By Drug Class: Analgesics, Anti-Depressants, Anti-Convulsants, Other Drug Classes

3) By Treatment: Drug Treatment, Radiotherapy, Physiotherapy, Other Treatments

4) By Distribution Channel: Online Distribution, Offline Distribution

5) By End-User: Hospitals, Specialty Clinics, Other End-Users

Subsegments:

1) By Peripheral Neuropathy: Distal Symmetric Neuropathy, Mononeuropathy, Polyneuropathy

2) By Autonomic Neuropathy: Cardiovascular Autonomic Neuropathy, Gastrointestinal Autonomic Neuropathy, Genitourinary Autonomic Neuropathy

3) By Proximal Neuropathy: Diabetic Amyotrophy, Lumbosacral Plexus Neuropathy

4) By Focal Neuropathy: Cranial Neuropathy, Cervical Radiculopathy, Other Focal Neuropathies

What Are the Leading Regions in the Diabetic Neuropathy Market Expansion?

North America was the largest region in the diabetic neuropathy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the diabetic neuropathy market during the forecast period. The regions covered in the diabetic neuropathy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

How Can We Define the Diabetic Neuropathy Market and Its Key Components?

Diabetic neuropathy is a type of nerve damage that can occur in people with diabetes. High blood sugar levels induce it, which can damage the blood vessels. It can harm various nerves in the body, including those in the feet, organs, and muscles.

Browse Through More Similar Reports By The Business Research Company:

Neurology Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/neurology-devices-global-market-report

Neurology Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/neurology-devices-global-market-report

Neurostimulation Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/neurostimulation-devices-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: